Hereditary Testing Market Size, Share & Trends Analysis Report By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing), By Technology, By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Market Scope & Segment Definition
1.4.1 Hereditary cancer testing
1.4.2 Hereditary non-cancer testing
1.4.2.1 Genetic tests
1.4.2.2 Newborn genetic screening
1.4.2.3 Preimplantation genetic diagnosis & screening
1.4.2.4 Non-invasive Prenatal Testing (NIPT) & carrier screening tests
1.5 Market Model
1.5.1 Hereditary cancer testing market
1.5.1.1 Market study
1.5.1.1.1 Price case study
1.5.1.1.2 Test provision study
1.5.1.1.3 Market competition study
1.5.1.1.4 Reimbursement study
1.5.1.2 Product mapping by cancer type & company
1.5.2 Hereditary non-cancer genetic testing market
1.5.2.1 Newborn genetic screening market
1.5.2.2 Preimplantation genetic testing market; NIPT & carrier screening market
Chapter 2 Executive Summary
2.1市场快照(20 21日数百万美元)
Chapter 3 Hereditary Testing Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.2 Market Dynamics
3.2.1米arket driver analysis
3.2.1.1 Increase in sales and demand for DNA test kits
3.2.1.2 Constantly developing commercial landscape of women's reproductive health
3.2.1.3 Decline in sequencing cost & consequent expansion of genetic testing registry
3.2.2市场约束分析
3.2.2.1 Ethical and clinical issues of DNA tests
3.2.2.2 Regulatory challenges pertaining to use of DTC genetic tests
3.2.3 Market opportunity analysis
3.2.3.1 Increasing incidence of genetic diseases
3.2.3.2 Presence of demand for early and non-invasive fetal testing procedures
3.2.3.3 Introduction of fragmented point-solutions across the genomics value chain
3.3 Industry Pyramid Analysis
3.4 Technology Mapping
3.4.1 PGS Technology Analysis
3.4.1.1 aCGH
3.4.1.2 NGS
3.4.1.3 Others
3.4.1.4 Introduction of technological advancements in cloud computing and data integration
3.5 Regulatory Landscape, by Geography
3.5.1 U.S.
3.5.2 Europe
3.5.2.1 Germany
3.5.3 China
3.5.4 Japan
3.6 Penetration & Growth Prospect Mapping, Disease Type, 20 21
3.7 Hereditary Testing Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.8 Industry Analysis - Porter’s Five Forces
Chapter 4 Hereditary Testing Market: Disease Type Estimates & Trend Analysis
4.1 Hereditary Testing Market: Disease Type Movement Analysis
4.2 Hereditary Cancer Testing
4.2.1 Global hereditary cancer testing market, 2018 - 2030 (USD Million)
4.2.2 Lung cancer
4.2.2.1 Global hereditary cancer testing market for lung cancer, 2018 - 2030 (USD Million)
4.2.3 Breast cancer
4.2.3.1 Global hereditary cancer testing market for breast cancer, 2018 - 2030 (USD Million)
4.2.4 Colorectal cancer
4.2.4.1 Global hereditary cancer testing market for colorectal cancer, 2018 - 2030 (USD Million)
4.2.5 Cervical cancer
4.2.5.1 Global hereditary cancer testing market for cervical cancer, 2018 - 2030 (USD Million)
4.2.6 Ovarian cancer
4.2.6.1 Global hereditary cancer testing market for ovarian cancer, 2018 - 2030 (USD Million)
4.2.7 Prostate cancer
4.2.7.1 Global hereditary cancer testing market for prostate cancer, 2018 - 2030 (USD Million)
4.2.8 Stomach/gastric cancer
4.2.8.1 Global hereditary cancer testing market for stomach/gastric cancer, 2018 - 2030 (USD Million)
4.2.9 Melanoma
4.2.9.1 Global hereditary cancer testing market for melanoma, 2018 - 2030 (USD Million)
4.2.10 Sarcoma
4.2.10.1 Global hereditary cancer testing market for sarcoma, 2018 - 2030 (USD Million)
4.2.11 Uterine cancer
4.2.11.1 Global hereditary cancer testing market for uterine cancer, 2018 - 2030 (USD Million)
4.2.1 2 Pancreatic cancer
4.2.1 2.1 Global hereditary cancer testing market for pancreatic cancer, 2018 - 2030 (USD Million)
4.2.13 Other cancers
4.2.13.1 Global hereditary cancer testing market for other cancers, 2018 - 2030 (USD Million)
4.3 Hereditary Non-cancer Testing
4.3.1 Global hereditary non-cancer testing market, 2018 - 2030 (USD Million)
4.3.2 Hereditary non-cancer genetic testing
4.3.2.1 Global hereditary non-cancer genetic testing market, 2018 - 2030 (USD Million)
4.3.2.2 Hereditary genetic testing for cardiac disease
4.3.2.2.1 Global hereditary genetic testing market for cardiac diseases, 2018 - 2030 (USD Million)
4.3.2.3 Hereditary genetic testing for rare disease
4.3.2.3.1 Global hereditary genetic testing market for rare diseases, 2018 - 2030 (USD Million)
4.3.2.4 Hereditary genetic testing for other diseases
4.3.2.4.1 Global hereditary genetic testing market for other diseases, 2018 - 2030 (USD Million)
4.3.3 Newborn genetic screening
4.3.3.1 Global newborn genetic screening market for inherited conditions, 2018 - 2030 (USD Million)
4.3.4 Preimplantation Genetic Diagnosis & Screening (PGD/PGS)
4.3.4.1 Global PGD/PGS market for inherited conditions, 2018 - 2030 (USD Million)
4.3.5 Non-invasive prenatal testing (NIPT) & carrier screening
4.3.5.1 Global non-invasive prenatal testing (NIPT) & carrier screening tests market for inherited conditions, 2018 - 2030 (USD Million)
Chapter 5 Hereditary Testing Market: Technology Estimates & Trend Analysis
5.1 Hereditary Testing Market: Technology Movement Analysis
5.2 Cytogenetic
5.2.1 Global cytogenetic hereditary testing market, 2018 - 2030 (USD Million)
5.3 Biochemical
5.3.1 Global biochemical hereditary testing market, 2018 - 2030 (USD Million)
5.4 Molecular Testing
5.4.1 Global molecular testing market, 2018 - 2030 (USD Million)
Chapter 6 Hereditary Testing Market Categorization: Regional Estimates & Trend Analysis by Disease Type
6.1 Hereditary Testing Market Share By Region
6.2 North America
6.2.1 North America hereditary testing market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.2.2.2 U.S. hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.2.3.2 Canada hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.2. Europe hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.3 U.K.
6.3.3.1. U.K. hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.3.2 U.K. hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.4 Germany
6.3.4.1 Germany hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.4.2 Germany hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.5.2 France hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.6.2 Spain hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.7 Italy
6.3.7.1 Italy hereditary testing market, by disease type, 2018 – 2030
6.3.7.2 Italy hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.3.8 Netherlands
6.3.8.1 Netherlands hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.3.8.2 Netherlands hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.2. Asia Pacific hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.3.1 China hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.4 Japan
6.4.4.1 Japan hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.4.2 Japan hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.5 India
6.4.5.1 India hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.5.2 India hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.6.2 South Korea hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.7 Australia
6.4.7.1 Australia hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.7.2澳大利亚hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.8 Singapore
6.4.8.1 Singapore hereditary testing market, by disease type, 2018- 2030
6.4.8.2 Singapore hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.4.9 South East Asia
6.4.9.1 South East Asia hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.4.9.2 South East Asia hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.5.2. Latin America hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.5.2.2 Brazil hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.6 Middle East and Africa (MEA)
6.6.1 MEA hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.6.2 MEA hereditary testing market, by technology, 2018 - 2030 (USD Million)
6.6.3 South Africa
6.6.2.1 South Africa hereditary testing market, by disease type, 2018 - 2030 (USD Million)
6.6.2.2 South Africa hereditary testing market, by technology, 2018 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 Major Deals & Strategic Alliances Analysis
7.1.1 Merger & acquisition deals
7.1.2 Product launches
7.1.3 Technological & marketing collaboration
7.2 Company Profiles
7.2.1 Myriad Genetics, Inc.
7.2.1.1 Company overview
7.2.1.2 Counsyl, Inc.
7.2.1.2.1 Company overview
7.2.1.3 Financial performance
7.2.1.4 Product benchmarking
7.2.1.5 Strategic initiatives
7.2.2 Invitae Corporation
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Illumina, Inc.
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Natera Inc.
7.2.4.1 Company overview
7.2.4.2 Financial performance (Novartis AG)
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5美国实验室公司控股
7.2.5.1 Company overview
7.2.5.1.1 Sequenom
7.2.5.2 Financial performance
7.2.5.3 Financial performance
7.2.5.4 Product benchmarking
7.2.5.5 Strategic initiatives
7.2.6 F. Hoffmann-La Roche Ltd.
7.2.6.1 Company overview
7.2.6.2 Ariosa Diagnostics
7.2.6.3 Financial performance
7.2.6.4 Product benchmarking
7.2.6.5 Strategic initiatives
7.2.7 Quest Diagnostics Incorporated
7.2.7.1 Company overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic initiatives
7.2.8 CooperSurgical, Inc.
7.2.8.1 Company overview
7.2.8.1.1 Genesis Genetics
7.2.8.1.2 Reprogenetics
7.2.8.2 Financial performance
7.2.8.3 Financial performance
7.2.8.4 Product benchmarking
7.2.8.5 Strategic initiatives
7.2.9 Agilent Technologies, Inc.
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 Thermo Fisher Scientific, Inc.
7.2.10.1 Company overview
7.2.10.1.1 Life Technologies Corp.
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives
7.2.11 Twist Bioscience
7.2.11.1 Company overview
7.2.11.2 Financial performance
7.2.11.3 Product benchmarking
7.2.11.4 Strategic initiatives
7.2.12 Sophia Genetics
7.2.1.2.1 Company overview
7.2.1.2.2 Financial performance
7.2.1 2.3 Product benchmarking
7.2.1 2.4 Strategic initiatives
7.2.13 Fulgent Genetics, Inc.
7.2.13.1 Company overview
7.2.13.2 Financial performance
7.2.13.3 Product benchmarking
7.2.13.4 Strategic initiatives
7.2.14 MedGenome
7.2.14.1 Company overview
7.2.14.2 Financial performance
7.2.14.3 Product benchmarking
7.2.15 CENTOGENE N.V.
7.2.15.1 Company overview
7.2.15.2 Financial performance
7.2.15.3 Product benchmarking
7.2.15.4 Strategic initiatives

List of Tables

Table 1 Product mapping for hereditary cancer tests
Table 2 DNA sequencing costs over the past decade
Table 3 Global incidence rate of genetic disorders
Table 4 Technology landscape for NIPT tests
Table 5 Comparison of other technologies
Table 6 Countries that prescribe mandatory medical supervision & restriction for genetic tests
Table 7 Susceptibility genes and their prevalence in hereditary ovarian syndromes
Table 8 Various NGS tests for hereditary prostate cancer
Table 9 Genetic testing scenario for patients/families affected by inherited cardiac disease
Table 10 Financial solutions for PGT:
Table 11 Commercial landscape of NIPT for fetal aneuploidy in the U.S.
Table 12 North America hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 13 North America hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 14 North America hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 15 North America hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 16 North America hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 17 U.S. hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 18 U.S. hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 19 U.S. hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
表20 U.S. hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 21 U.S. hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 2 2 Canada hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 23 Canada hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 24 Canada hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 25 Canada hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 26 Canada hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 27 Europe hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 28 Europe hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 29 Europe hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 30 Europe hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 31 Europe hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 32 U.K. hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 33 U.K. hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 34 U.K. hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 35 U.K. hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 36 U.K. hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 37 Germany hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 38 Germany hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 39 Germany hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 40 Germany hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 41 Germany hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 France hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 43 France hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 44 France hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 45 France hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 46 France hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 47 Spain hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 48 Spain hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 49 Spain hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 50 Spain hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 51 Spain hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 52 Italy hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 53 Italy hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 54 Italy hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 55 Italy hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 56 Italy hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 57 Netherlands hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 58 Netherlands hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 59 Netherlands hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 60 Netherlands hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 61 Netherlands hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 62 Asia Pacific hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
表63年亚太马遗传性癌症检测rket estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 65 Asia Pacific hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 66 Asia Pacific hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 67 China hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
表68年中国世袭cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 69 China hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 70 China hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 71 China hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 72 Japan hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 73 Japan hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 74 Japan hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 75 Japan hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 76 Japan hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 77 India hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 78 India hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 79 India hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 80 India hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 81 India hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 82 South Korea hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 83 South Korea hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 84 South Korea hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 85 South Korea hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 86 South Korea hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 87 Australia hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 88 Australia hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 89 Australia hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 90 Australia hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 91 Australia hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 92 Singapore hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 93 Singapore hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 94 Singapore hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 95 Singapore hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 96 Singapore hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 97 South East Asia hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 98 South East Asia hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 99 South East Asia hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 100 South East Asia hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 101 South East Asia hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 102 Latin America hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 103 Latin America hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 104 Latin America hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 105 Latin America hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 106 Latin America hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 107 Brazil hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 108 Brazil hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 109 Brazil hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 110 Brazil hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 111 Brazil hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 112 MEA hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 113 MEA hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 114 MEA hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 115 MEA hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 116 MEA hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 117 South Africa hereditary testing market estimates & forecasts, by disease type, 2018 - 2030 (USD Million)
Table 118 South Africa hereditary cancer testing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 119 South Africa hereditary non-cancer testing market estimates & forecasts, by test type, 2018 - 2030 (USD Million)
Table 120 South Africa hereditary non-cancer genetic testing market estimates & forecasts, by conditions, 2018 - 2030 (USD Million)
Table 121 South Africa hereditary testing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Hereditary Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping, 20 21
Fig. 15 Regional Marketplace: Key Takeaways
Fig. 16 Regional Outlook, 20 21 & 2030
Fig. 17 North America Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 18 U.S. Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 19 Canada Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 20 Europe Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 21 Germany Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 22 UK Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 23 France Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 24 Spain Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 25 Italy Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 26 Netherlands Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 27 Asia Pacific Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 28 Japan Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 29 China Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 30 India Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 31 Australia Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 32 South Korea Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 33 Latin America Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 34 Brazil Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 35 Mexico Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 36 Middle East and Africa Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 37 South Africa Hereditary Testing Market, 2018 - 2030 (USD Million)
Fig. 38 Global Hereditary Testing Market, for, Hereditary Cancer Testing 2018 - 2030 (USD Million)
Fig. 39 Global Hereditary Testing Market, for, Lung Cancer 2018 - 2030 (USD Million)
Fig. 40 Global Hereditary Testing Market, for, Breast Cancer 2018 - 2030 (USD Million)
Fig. 41 Global Hereditary Testing Market, for, Colorectal Cancer 2018 - 2030 (USD Million)
Fig. 42 Global Hereditary Testing Market, for, Cervical Cancer 2018 - 2030 (USD Million)
Fig. 43 Global Hereditary Testing Market, for, Ovarian Cancer 2018 - 2030 (USD Million)
图44全球遗传测试市场,专业state Cancer 2018 - 2030 (USD Million)
Fig. 45 Global Hereditary Testing Market, for, Stomach/Gastric Cancer 2018 - 2030 (USD Million)
Fig. 46 Global Hereditary Testing Market, for, Melanoma 2018 - 2030 (USD Million)
Fig. 47 Global Hereditary Testing Market, for, Sarcoma 2018 - 2030 (USD Million)
Fig. 48 Global Hereditary Testing Market, for, Uterine Cancer 2018 - 2030 (USD Million)
Fig. 49 Global Hereditary Testing Market, for, Pancreatic Cancer 2018 - 2030 (USD Million)
Fig. 50 Global Hereditary Testing Market, for, Others 2018 - 2030 (USD Million)
Fig. 51 Global Hereditary Testing Market, for, Genetic Tests 2018 - 2030 (USD Million)
Fig. 52 Global Hereditary Testing Market, for, Cardiac Diseases 2018 - 2030 (USD Million)
Fig. 53 Global Hereditary Testing Market, for, Rare Diseases 2018 - 2030 (USD Million)
Fig. 54 Global Hereditary Testing Market, for, Other Diseases 2018 - 2030 (USD Million)
Fig. 55 Global Hereditary Testing Market, for, Newborn Genetic Screening 2018 - 2030 (USD Million)
Fig. 56 Global Hereditary Testing Market, for, Preimplantation Genetic Diagnosis & Screening 2018 - 2030 (USD Million)
Fig. 57 Global Hereditary Testing Market, for, Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests 2018 - 2030 (USD Million)
Fig. 58 Global Hereditary Testing Market, for, Cytogenetic 2018 - 2030 (USD Million)
Fig. 59 Global Hereditary Testing Market, for, Biochemical 2018 - 2030 (USD Million)
Fig. 60 Global Hereditary Testing Market, for, Molecular Testing 2018 - 2030 (USD Million)